Test | City | Species | (nr/np/nt)(a) | Sens(b)(%) | Spe(c)(%) | Ac(d)(%) | Kappa(e) | p(f) |
---|
BC | Botucatu (SP) | Dog | (3/0/50) | – | 94.0 | – | – | – |
Cat | (2/0/50) | – | 96.0 | – | – | – |
Campo Grande (MS) | Dog | (29/36/50) | 69.4 | 71.4 | 70.0 | 0.35 | 0.009 |
Cat | (0/0/50) | – | 100.0 | – | – | – |
IFAT | Botucatu (SP) | Dog | (0/0/50) | – | 100.0 | – | – | – |
Cat | (0/0/50) | – | 100.0 | – | – | – |
Campo Grande (MS) | Dog | (32/36/50) | 80.6 | 78.6 | 80.0 | 0.54 | < 0.01 |
| | Cat | (15/0/50) | – | 70.0 | – | – | – |
- BC blood culture, IFAT immunofluorescent antibody test.
- (a)nr: number of positive leishmaniasis diagnoses through BC or IFAT; np: number of positive diagnoses for Leishmania spp. through PCR exam; nt: total number of dogs.
- (b)Sensitivity estimate (% of true positives for leishmaniasis).
- (c)Specificity estimate (% of true negatives for leishmaniasis).
- (d)Accuracy estimate (% of correct diagnosis through hemoculture and IFAT).
- (e)Kappa coefficient of concordance.
- (f)Descriptive level associated with estimated kappa coefficient.